Page last updated: 2024-11-05

isobutyl acetate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Isobutyl acetate, also known as isobutyl ethanoate, is a colorless liquid with a fruity odor. It is commonly used as a solvent in various industries. It is also a component of many fragrances and flavors. Isobutyl acetate can be synthesized through the esterification reaction of isobutyl alcohol with acetic acid in the presence of a catalyst, such as sulfuric acid. It is studied for its potential applications in various fields, including as a biofuel and as a building block for the synthesis of other chemicals. It is also known to have antimicrobial and antifungal properties. Isobutyl acetate is generally considered safe for human use in low concentrations. However, exposure to high concentrations can cause irritation to the eyes, skin, and respiratory tract.'

isobutyl acetate : The acetate ester of isobutanol. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID8038
CHEMBL ID46999
CHEBI ID50569
SCHEMBL ID22678
MeSH IDM0117027

Synonyms (87)

Synonym
LS-13178
2-methylpropyl ethanoate
.beta.-methylpropyl ethanoate
acetic acid, isobutyl ester
2-methylpropyl acetate
nsc-8035
wln: 1y1 & 1ov1
acetic acid, 2-methylpropyl ester
isobutyl acetate
nsc8035
acetate d'isobutyle
isobutyl ethanoate
110-19-0
2-methyl-1-propyl acetate
beta-methylpropyl ethanoate
isobutyl acetate [un1213] [flammable liquid]
acetate d'isobutyle [french]
fema number 2175
fema no. 2175
isobutylester kyseliny octove [czech]
ai3-15305
hsdb 609
einecs 203-745-1
nsc 8035
brn 1741909
isobutyl acetate (natural)
un1213
inchi=1/c6h12o2/c1-5(2)4-8-6(3)7/h5h,4h2,1-3h
isobutyl acetate, natural, >=97%, fcc, fg
isobutyl acetate, >=98%, fcc, fg
isobutylacetat
isobutylazetat
i-butyl acetate
essigsaeureisobutylester
CHEBI:50569 ,
A0034
acetic acid isobutyl ester
CHEMBL46999
NCGC00249107-01
7cr47fo6lf ,
unii-7cr47fo6lf
4-02-00-00149 (beilstein handbook reference)
ec 203-745-1
isobutyl acetate [un1213] [flammable liquid]
isobutylester kyseliny octove
cas-110-19-0
NCGC00259284-01
tox21_201735
dtxsid5026837 ,
dtxcid906837
STL280347
FT-0621747
AKOS015901357
isobutyl acetate [usp-rs]
isobutyl acetate [mi]
isobutyl acetate [fcc]
isobutyl acetate [inci]
isobutyl acetate [hsdb]
isobutyl acetate [fhfi]
SCHEMBL22678
iso-butylacetate
acoibu
iso-butyl acetate
2-methyl-1-propanol, acetate
un 1213
J-002396
isobutyl acetate, analytical standard
mfcd00008932
isobutyl acetate, united states pharmacopeia (usp) reference standard
isobutyl acetate, 99%
isobutyl acetate; acetic acid-isobutyl ester
acetic acid-isobutyl ester
2-methylpropyl acetate, 9ci
isobutyl acetate fcc
fema 2175
beta -methylpropyl ethanoate
isobutyl acetate, 8ci
F0001-0218
Q420657
acetic acid-isobutyl ester 1000 microg/ml in acetonitrile
tri isobutyl acetate
ibac
beta-methylpropyl acetate
tri iso butyl acetate
iso butyl acetate
tri ibac
isobutyl acetate (usp-rs)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
Saccharomyces cerevisiae metaboliteAny fungal metabolite produced during a metabolic reaction in Baker's yeast (Saccharomyces cerevisiae).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
acetate esterAny carboxylic ester where the carboxylic acid component is acetic acid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
estrogen nuclear receptor alphaHomo sapiens (human)Potency27.81300.000229.305416,493.5996AID743069; AID743078
activating transcription factor 6Homo sapiens (human)Potency60.27470.143427.612159.8106AID1159516
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency33.60860.000323.4451159.6830AID743066
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID212400Toxicity determined using Tadpole Narcosis Test1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
Using theoretical descriptors in quantitative structure-activity relationships: some toxicological indices.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (16.67)18.2507
2000's2 (11.11)29.6817
2010's10 (55.56)24.3611
2020's3 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 58.19

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index58.19 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index5.02 (4.65)
Search Engine Demand Index90.66 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (58.19)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (10.53%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other17 (89.47%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]